What happened: The US Supreme Court has paused a lower court's order requiring in-person visits to obtain the abortion pill mifepristone, restoring access to the medication by mail.
Why it matters:
- This decision affects patients seeking abortion care, allowing easier access to medication.
- It impacts healthcare providers and regulatory practices around abortion services nationwide.
MNN Take: The Supreme Court's temporary ruling maintains previous FDA rules permitting mail delivery of mifepristone while further legal review continues.
Sources: NYTimes US